AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7659873
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline (250 ml)
Trial: 7659873
Drug: Buffer therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buffer therapy (sodium bicarbonate)
Trial: 6118631
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg ergocalciferol (oral and intramuscular administration)
Trial: 6118631
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg ergocalciferol (oral administration)
Trial: 6118631
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg ergocalciferol (once a year regimen)
Trial: 27629405
Drug: Personalised Hip
RxNorm normalized name: HIP
DrugBank: Heme iron polypeptide (DB11067)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalised Hip Therapy (PHT)
Trial: 24829210
Drug: Deep-TMS treatment
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep-TMS treatment (20 daily sessions at 20Hz, 120% MT)
Trial: 17642239
Drug: Rituximab with
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab with concomitant MTX therapy
Trial: 16313283
Drug: Tramadol 37.5
RxNorm normalized name: ACETAMINOPHEN 325MG/TRAMADOL 37.5MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 37.5 mg/paracetamol 325 mg
Trial: 16313283
Drug: Codeine 30
RxNorm normalized name: codeine 30 MG
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Codeine 30 mg/paracetamol 500 mg
Trial: 31794027
Drug: mhGAP-based training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mhGAP-based training (6 weeks, weekly sessions including lectures, discussions, role plays, and support sessions)
Trial: 24708386
Drug: Treatment-as-usual (TAU)
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual (TAU) condition (n = 126)
Trial: 17566314
Drug: Amlodipine 10
RxNorm normalized name: amlodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 10 mg/day (monotherapy)
Trial: 17566314
Drug: Amlodipine/benazepril 10/40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine/benazepril 10/40 mg/day and 10/20 mg/day
Trial: 9186989
Drug: Long-term corticosteroid
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term corticosteroid treatment
Trial: 3895381
Drug: Novaluzid (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novaluzid (10 ml seven times daily)
Trial: 25516019
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT), 10 sessions
Trial: 22961466
Drug: Caregiving Stressors
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caregiving Stressors (daily care bother, behavioral bother, burden)
Trial: 14501025
Drug: Cholesterol-lowering treatment
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol-lowering treatment (statins)
Trial: 8739113
Drug: L‐tryptophan (L‐TRP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐tryptophan (L‐TRP)
Trial: 8739113
Drug: L‐TRP
RxNorm normalized name: L-TRP is the abbreviation for L-Tryptophan.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐TRP
Trial: 7034758
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine in 8% dextrose, 2 ml, 3 ml, or 4 ml
Trial: 7034758
Drug: 0.75% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% bupivacaine in 8% dextrose, 1.3 ml or 2 ml
Trial: 7034758
Drug: 0.75% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% bupivacaine in 8% dextrose, 3 ml
Trial: 7034758
Drug: Both solutions
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both solutions (0.5% and 0.75%)
Trial: 25136017
Drug: KAF156 single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KAF156 single dose (10 to 1,200 mg)
Trial: 25136017
Drug: KAF156 multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KAF156 multiple doses (60 to 600 mg once daily for 3 days)
Trial: 25136017
Drug: KAF156 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KAF156 (400 mg) under fed conditions
Trial: 25136017
Drug: KAF156 (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KAF156 (single and multiple doses)
Trial: 20633284
Drug: Surfactant (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant (200 mg/kg/dose, 3 doses at 0, 12, and 36 hours)
Trial: 17438344
Drug: Care as
RxNorm normalized name: TopCare Aspirin 325mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Care as usual (family therapy or behavior therapy)
Trial: 15677866
Drug: Donepezil (5.87
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (5.87 mg/day, SD = 1.92)
Trial: 15677866
Drug: Galantamine (14.81
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine (14.81 mg/day, SD = 6.25)
Trial: 15677866
Drug: Rivastigmine (6.41
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivastigmine (6.41 mg/day, SD = 1.82)
Trial: 12797647
Drug: Valdecoxib 10
RxNorm normalized name: valdecoxib 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib 10 mg once a day for 4 weeks
Trial: 9583851
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose lipid (25-30% of total daily energy)
Trial: 9583851
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose lipid (6-8% of total daily energy)
Trial: 10327712
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of spraying plus housing improvement
Trial: 6337038
Drug: heparin 5000
RxNorm normalized name: HEPARIN 5000 UNT/ML SYRINGE 1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: heparin 5000
Trial: 6337038
Drug: heparin 2500
RxNorm normalized name: heparin 2500 units/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: heparin 2500
Trial: 6337038
Drug: heparin 2500
RxNorm normalized name: heparin 2500 units/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: heparin 2500 and 0.5 mg dihydroergotamine (HDHE 2500)
Trial: 6337038
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg dihydroergotamine (DHE)
Trial: 15193477
Drug: Aspirin 75
RxNorm normalized name: aspirin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 75 mg daily from the day of embryo transfer until pregnancy test
Trial: 10994153
Drug: myrtol standardized
RxNorm normalized name: myrtol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: myrtol standardized (4 x 300 mg, day 1‐14)
Trial: 10994153
Drug: cefuroxime (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cefuroxime (2 x 250 mg daily for day 1‐6)
Trial: 10994153
Drug: ambroxol (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ambroxol (3 x 30 mg for day 1‐3, 2 x 30 mg for days 4‐14)
Trial: 30210070
Drug: MitraClip (MC)
RxNorm normalized name: MC-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MitraClip (MC) treatment
Trial: 24343788
Drug: Operated knees
RxNorm normalized name: Bos taurus knee joint preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operated knees (T2 values of suprapatellar subcutaneous adipose tissue)
Trial: 24343788
Drug: Control knees
RxNorm normalized name: Bos taurus knee joint preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control knees (T2 values of suprapatellar subcutaneous adipose tissue)
Trial: 22732113
Drug: Single-lumen tracheal
RxNorm normalized name: Luden's
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-lumen tracheal tube with Arndt® blocker
Trial: 17585665
Drug: Chinese herbs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbs with modified Buzhong Yiqi Decoction, one dose each day, 10 doses per course.
Trial: 17585665
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine with bandazol, Dextran 40, Danshen tablet, and vitamin B12, 10 days per course.
Trial: 12167139
Drug: Amitriptyline combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline combined with fluoxetine (group 2)
Trial: 10209075
Drug: Lisinopril, 20
RxNorm normalized name: Lisinopril, 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril, 20 mg/day (n=20)
Trial: 9456943
Drug: Manual injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual injection at 2 ml/sec (Group 1)
Trial: 9456943
Drug: Automatic injection
RxNorm normalized name: AMMONIA,AROMATIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automatic injection at 2 ml/sec (Group 3)
Trial: 9456943
Drug: Automatic injection
RxNorm normalized name: AMMONIA,AROMATIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automatic injection at 4 ml/sec (Group 4)
Trial: 9456943
Drug: Automatic injection
RxNorm normalized name: AMMONIA,AROMATIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automatic injection at 6 ml/sec (Group 5)
Trial: 31141198
Drug: Immediate loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate loading of two implants supporting a locator-retained mandibular overdenture
Trial: 31141198
Drug: Delayed loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed loading of two implants supporting a locator-retained mandibular overdenture
Trial: 25832995
Drug: Low-dose (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose (0.6 mg/kg body weight; maximum 60 mg) i.v. rt-PA
Trial: 25832995
Drug: Standard-dose (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose (0.9 mg/kg body weight; maximum 90 mg) i.v. rt-PA
Trial: 23525080
Drug: Non-viral, liposome-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-viral, liposome-based gene therapy formulation
Trial: 21457152
Drug: Sildenafil (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (0.5 mg.kg(‐1))
Trial: 17110217
Drug: Dutasteride 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.05 mg
Trial: 17110217
Drug: Dutasteride 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.1 mg
Trial: 11316141
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg b.i.d.
Trial: 8187254
Drug: Intravenous group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous group
Trial: 30122896
Drug: Leucostim® (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leucostim® (5 μg/kg)
Trial: 30122896
Drug: Leucostim® (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leucostim® (10 μg/kg)
Trial: 30122896
Drug: Neupogen® (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neupogen® (5 μg/kg)
Trial: 30122896
Drug: Neupogen® (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neupogen® (10 μg/kg)
Trial: 18663723
Drug: Darifenacin 7.5/15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darifenacin 7.5/15 mg once daily (o.d.)
Trial: 12182381
Drug: M-M-R II
RxNorm normalized name: M-M-R II
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M-M-R II and VARIVAX administered 6 weeks apart (Group B)
Trial: 8575573
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (BDP) 200 micrograms b.i.d. for 3 months
Trial: 375881
Drug: Penicillamine treatment
RxNorm normalized name: Penicillamine
DrugBank: Penicillamine (DB00859)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillamine treatment (250 mg, 3 capsules per day)
Trial: 375881
Drug: Placebo (lactose,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (lactose, 3 capsules per day)
Trial: 28633675
Drug: Jiao's scalp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jiao's scalp acupuncture combined with conventional rehabilitation treatment
Trial: 26426042
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg intramuscular phylloquinone
Trial: 26426042
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg intramuscular phylloquinone
Trial: 26426042
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg intravenous phylloquinone
Trial: 26426042
Drug: Bolus dose
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus dose of phylloquinone at birth
Trial: 23110811
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy (CT) with epirubicin 120 mg/m² and ifosfamide 9 g/m² followed by two postoperative cycles
Trial: 23110811
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy (CT) with radiotherapy (RT)
Trial: 20963831
Drug: Tobramycin inhalation
RxNorm normalized name: Tobramycin Inhalation Powder
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycin inhalation powder (112 mg, twice daily)
Trial: 20963831
Drug: Tobramycin inhalation
RxNorm normalized name: Tobramycin Inhalation Powder
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycin inhalation powder
Trial: 19197779
Drug: Web-based course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based course on cognitive behavioral therapy (CBT)
Trial: 15589109
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of galantamine (GAL)
Trial: 11064501
Drug: Triple antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple antiretroviral therapy (two nucleoside reverse transcriptase inhibitors (NRTIs) plus one protease inhibitor)
Trial: 11064501
Drug: Double therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double therapy (two NRTIs)
Trial: 11064501
Drug: Double therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double therapy and Triple therapy
Trial: 8144850
Drug: Goserelin depot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin depot formulation 3.6 mg every 28 days for 6 months (first implant in early follicular phase)
Trial: 8144850
Drug: Goserelin depot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin depot formulation 3.6 mg every 28 days for 6 months (first implant in late luteal phase)
Trial: 8144850
Drug: Goserelin depot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin depot formulation 3.6 mg every 28 days for 6 months (first implant on 3rd and 17th day from onset of menses)
Trial: 29976078
Drug: 0.1 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 g/kg multi-strain probiotic (MS)
Trial: 29976078
Drug: 0.1 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 g/kg single-strain probiotic (SS)
Trial: 29976078
Drug: 0.1 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 g/kg of both probiotics (MS+ SS)
Trial: 29976078
Drug: 0.5 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g/kg oxytetracycline antibiotic (OX)
Trial: 20980654
Drug: Aleurone-rich cereal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aleurone-rich cereal products (27 g/d aleurone)
Trial: 15304189
Drug: 5% ascorbic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% ascorbic acid cream
Trial: 8507449
Drug: Potassium canrenoate
RxNorm normalized name: Potassium canrenoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium canrenoate (100 mg/day, orally for 1 month)
Trial: 3431029
Drug: Polyenylphosphatidylcholine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyenylphosphatidylcholine (10 g per day)
Trial: 3431029
Drug: Safflower oil
RxNorm normalized name: Safflower Oil
DrugBank: Safflower oil (DB09446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Safflower oil (7 g per day)
Trial: 28570305
Drug: Immersive Virtual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immersive Virtual Reality (IVR) distraction therapy
Trial: 11710653
Drug: Ginseng (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginseng (400 mg per day of G115)
Trial: 9024299
Drug: Oral calcium
RxNorm normalized name: Coral Calcium
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcium phosphate supplementation
Trial: 7984562
Drug: Specially designed
RxNorm normalized name: epinephrine / mepivacaine hydrochloride Injectable Solution [Scandonest 2% Special]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specially designed diagnostic preparations made of TB and BCG vaccine strain tuberculin
Trial: 2880497
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no beta-blocking drugs)
Trial: 29247383
Drug: Platinum-based doublet
RxNorm normalized name: platinum
DrugBank: Platinum (DB12257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platinum-based doublet chemotherapy
Trial: 27938361
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of spa therapy, exercise, and self-management workshops for 6 days
Trial: 25535778
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (including sealing and no treatment)
Trial: 17622255
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg Zn/day
Trial: 17622255
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg Zn/day
Trial: 17200730
Drug: Various drugs
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various drugs including 5‐Methyltetrahydrofolate, (R)‐flurbiprofen, Ad5CMV‐p53, adalimumab, alefacept, alemtuzumab, Alequel, alicaforsen sodium, almotriptan, anakinra, aprepitant, aripiprazole, armodafinil, Bevacizumab, bortezomib, bosentan, Canfosfamide hydrochloride, ciclesonide, clofarabine, Cypher, Darbepoetin alfa, diclofenac potassium, drotrecogin alfa (activated), duloxetine hydrochloride, Eel calcitonin, eletriptan, eplerenone, everolimus, ezetimibe, Frovatriptan, Gefitinib, γ‐hydroxybutyrate sodium, HKI‐272, HYB‐165, Ibutamoren mesylate, imatinib mesylate, interleukin‐21, ixabepilone, KRN‐951, L‐Arginine hydrochloride, levodopal carbidopa/entacapone, Micafungin sodium, motexafin gadolinium, mycophenolic acid sodium salt, Nesiritide, Peginterferon alfa‐2a, pitavastatin calcium, pralatrexate, pregabalin, pVAX/L523S‐Ad.L523S, Rasagiline mesylate, recombinant human nerve growth factor, regadenoson, rF‐PSA, rimonabant, rizatriptan, rofecoxib, rosuvastatin calcium, rV‐B7.1, rV‐PSA, Sipuleucel‐T, sirolimus‐eluting stent, solifenacin succinate, sorafenib, sunitinib malate, Talactoferrin alfa, Taxus, tegaserod maleate, teriparatide, tipifarnib, Valdecoxib, vandetanib, vatalanib succinate, WT1‐peptide vaccine, Xaliproden hydrochloride
Trial: 13129416
Drug: Oral tegafur
RxNorm normalized name: tegafur
DrugBank: Tegafur (DB09256)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Oral tegafur plus uracil (UFT) plus folinic acid
Trial: 13129416
Drug: Intravenous fluorouracil
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fluorouracil (FU) plus oral folinic acid (leucovorin)
Trial: 10632648
Drug: RBC 400
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC 400 mg b.d. plus clarithromycin 500 mg b.d. and tinidazole 500 mg b.d. (RBCCT group)
Trial: 10632648
Drug: RBC 400
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC 400 mg b.d. plus clarithromycin 500 mg b.d. and amoxycillin 1 g b.d. (RBCCA group)
Trial: 8619505
Drug: Inhaled exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled exposure to carbon monoxide at sea level
Trial: 8619505
Drug: Inhaled exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled exposure to carbon monoxide at high altitude
Trial: 8619505
Drug: Inhaled exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled exposure to clean air at sea level
Trial: 8619505
Drug: Inhaled exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled exposure to clean air at high altitude
Trial: 28855223
Drug: DASH diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DASH diet (low in fat and high in protein, low-fat dairy, and fruits and vegetables) with high sodium (150 nmol or 3450 mg)
Trial: 28855223
Drug: DASH diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DASH diet with medium sodium (100 nmol or 2300 mg)
Trial: 28855223
Drug: DASH diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DASH diet with low sodium (50 nmol or 1150 mg)
Trial: 25935787
Drug: 0.3‐mg intravitreal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3‐mg intravitreal ranibizumab injection therapy